CN Stock MarketDetailed Quotes

688098 Shanghai Shen Lian Biomedical Corporation

Watchlist
  • 5.41
  • +0.01+0.19%
Trading Nov 26 14:37 CST
2.22BMarket Cap-112708P/E (TTM)

Shanghai Shen Lian Biomedical Corporation Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
169.49%105.11M
-7.09%138.28M
-10.77%40.94M
-14.73%44.98M
54.11%39.01M
130.91%148.84M
-13.51%45.88M
19.29%52.74M
-69.53%25.31M
-64.26%64.46M
Transactional financial assets
-57.87%60.96M
-55.22%40.51M
-50.46%132.32M
-46.78%162.38M
-51.65%144.68M
-69.30%90.45M
-24.72%267.09M
-28.05%305.12M
-15.93%299.22M
-0.35%294.66M
Notes receivable and accounts receivable
-3.15%315.11M
5.83%272.3M
17.12%313.4M
22.99%273.97M
8.15%325.35M
31.55%257.29M
21.71%267.58M
44.07%222.76M
36.99%300.84M
24.06%195.58M
-Notes receivable
----
----
----
----
----
----
-98.68%33.12K
-83.20%604.82K
--2.52M
--1.92M
-Accounts receivable
-3.15%315.11M
5.83%272.3M
17.14%313.4M
23.33%273.97M
9.06%325.35M
32.86%257.29M
23.09%267.55M
47.11%222.15M
35.84%298.31M
22.84%193.66M
Other receivables (including interest and dividends)
-7.32%3.58M
25.12%3.84M
-22.78%4.83M
-54.71%3.09M
-42.02%3.86M
-64.62%3.07M
1.66%6.25M
13.68%6.82M
7.94%6.65M
34.92%8.68M
-Other receivable
----
25.12%3.84M
----
-54.71%3.09M
----
-64.62%3.07M
----
13.68%6.82M
----
34.92%8.68M
Advance payment
-70.62%1.17M
-81.06%1.17M
-36.72%1.8M
-23.64%2.09M
-7.68%4M
-8.14%6.2M
61.27%2.85M
139.96%2.74M
267.24%4.33M
583.62%6.75M
Inventories
-17.42%95.05M
-5.76%114.2M
1.04%112M
-3.07%111.79M
8.60%115.11M
0.10%121.18M
7.39%110.85M
11.51%115.33M
3.60%106M
70.78%121.06M
Other current assets
--59.66K
-91.14%56.52K
----
----
----
--637.79K
----
----
----
----
Total current assets
-8.06%581.04M
-9.13%570.36M
-13.59%605.3M
-15.20%598.29M
-14.87%632M
-9.19%627.66M
-5.19%700.5M
-3.81%705.5M
-3.37%742.35M
-2.93%691.19M
Non Current assets
Fixed assets
----
-1.24%651.51M
----
-2.79%658.33M
----
-4.52%659.7M
----
6.78%677.24M
----
16.01%690.96M
Constru in process
----
28.73%156.52M
----
65.18%163.44M
----
43.40%121.6M
----
-26.04%98.95M
----
-35.49%84.79M
Productive biological assets
--139.36K
--156.97K
--197.1K
--206.46K
----
----
----
----
----
----
Intangible assets
10.06%104.97M
39.25%107.17M
99.97%104.56M
76.20%93.6M
182.83%95.37M
136.43%76.96M
60.91%52.29M
62.65%53.12M
3.55%33.72M
-0.72%32.55M
Development expenditure
21.80%49.9M
19.38%45.86M
-30.45%31.06M
0.44%42.35M
-27.10%40.97M
-12.98%38.42M
10.26%44.66M
18.70%42.17M
127.72%56.19M
166.81%44.15M
Deferred tax assets
-1.96%7.27M
-13.23%5.74M
-18.76%5.51M
-20.99%5.14M
-11.32%7.41M
-20.83%6.61M
-9.90%6.78M
-8.18%6.5M
-4.77%8.36M
-15.29%8.35M
Usufruct assets
39.12%1.96M
53.44%2.29M
-20.95%1.24M
182.92%1.33M
180.02%1.41M
201.18%1.49M
198.76%1.57M
-16.04%468.82K
-14.72%503.13K
-20.34%495.15K
Other non current assets
-3.70%28.43M
-14.47%15.98M
31.23%28.29M
51.96%29.72M
39.22%29.52M
-23.05%18.68M
11.13%21.56M
-0.29%19.56M
-39.81%21.21M
-5.44%24.27M
Total non current assets
2.20%1B
6.68%986.81M
9.91%988.85M
10.69%995.7M
8.99%979.38M
4.27%925.04M
2.76%899.67M
4.00%899.58M
6.38%898.63M
8.98%887.15M
Total assets
-1.82%1.58B
0.29%1.56B
-0.38%1.59B
-0.69%1.59B
-1.80%1.61B
-1.62%1.55B
-0.88%1.6B
0.41%1.61B
1.73%1.64B
3.42%1.58B
Liabilities
Current liabilities
Notes payable and accounts payable
-14.60%8.27M
-52.57%3.5M
42.32%10.3M
-41.94%5.14M
-43.59%9.69M
-43.85%7.39M
-43.37%7.23M
-21.82%8.86M
5.07%17.17M
111.47%13.16M
-Accounts payable
-14.60%8.27M
-52.57%3.5M
42.32%10.3M
-41.94%5.14M
-43.59%9.69M
-43.85%7.39M
-43.37%7.23M
-21.82%8.86M
5.07%17.17M
111.47%13.16M
Contract liabilities
25.03%12.29M
19.30%18.54M
27.28%8.36M
-36.73%6.65M
-15.15%9.83M
-7.59%15.54M
132.14%6.57M
26.24%10.51M
-61.77%11.59M
-20.72%16.81M
Salaries payable
115.41%13.66M
49.60%9.32M
48.51%7.95M
-11.59%18.22M
-60.25%6.34M
-42.42%6.23M
-37.87%5.35M
-13.48%20.61M
-7.90%15.96M
-13.50%10.82M
Taxs payable
-61.93%2.87M
38.04%1.13M
-46.88%5.03M
-82.11%2.35M
-69.42%7.54M
-93.77%818.63K
-41.56%9.47M
50.92%13.11M
90.87%24.64M
209.97%13.14M
Other payable (including interest and dividends)
38.83%45.77M
66.75%44.62M
10.52%38.21M
8.42%33.88M
0.20%32.96M
-14.51%26.76M
-23.72%34.58M
-29.63%31.25M
-10.44%32.9M
-23.36%31.3M
-Dividend payable
6.56%553.01K
-47.07%1.88M
17.65%518.95K
17.65%518.95K
17.65%518.95K
705.15%3.55M
50.00%441.1K
50.00%441.1K
50.00%441.1K
50.00%441.1K
-Other payable
----
84.17%42.74M
----
8.29%33.36M
----
-24.80%23.21M
----
-30.16%30.81M
----
-23.90%30.86M
Non current liabilities due within one year
50.37%520.13K
62.29%563.04K
-5.36%329.87K
145.41%333.81K
150.21%345.91K
169.89%346.94K
167.90%348.56K
3.29%136.02K
3.74%138.25K
-4.67%128.55K
Other current liabilities
-5.28%11.22M
11.75%10.78M
-14.85%9.9M
-22.06%9.93M
-10.90%11.84M
-45.44%9.65M
-33.16%11.63M
-24.27%12.74M
-35.11%13.29M
-19.24%17.68M
Total current liabilities
20.43%94.6M
32.56%88.46M
6.52%80.08M
-21.31%76.5M
-32.10%78.55M
-35.25%66.73M
-27.21%75.18M
-14.37%97.22M
-13.82%115.69M
-3.74%103.05M
Current liabilities
Long term account payable
----
----
----
----
----
----
----
----
----
--0
Specific account payable
----
----
----
----
----
----
----
----
----
--100K
Deferred tax liabilities
-81.23%73.51K
-95.09%14.25K
-98.40%10.73K
-94.44%17.88K
97.31%391.6K
-1.11%290.53K
93.65%669.38K
20.71%321.82K
45.70%198.47K
178.63%293.8K
Long term deferred income
7.46%10.43M
8.91%10.81M
-8.63%9.27M
-8.45%9.49M
-8.28%9.71M
-8.11%9.93M
-7.95%10.15M
-8.27%10.36M
-6.62%10.58M
-7.10%10.8M
Lease liabilities
36.32%1.23M
65.37%1.63M
-21.41%842.56K
195.92%917.19K
195.81%899.97K
178.73%985.8K
206.38%1.07M
-18.91%309.94K
-26.59%304.24K
-20.83%353.68K
Total non current liabilities
6.66%11.73M
11.18%12.45M
-14.84%10.12M
-5.21%10.42M
-1.67%11M
-3.00%11.2M
1.45%11.89M
-7.96%11M
-5.87%11.19M
-5.18%11.55M
Total liabilities
18.74%106.34M
29.49%100.91M
3.60%90.21M
-19.67%86.93M
-29.42%89.55M
-32.00%77.93M
-24.29%87.07M
-13.76%108.21M
-13.17%126.88M
-3.89%114.6M
Shareholders equity
Paid-in capital
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.00%410.64M
0.23%410.64M
Capital reserve funds
-1.48%539.23M
-1.39%539.23M
-1.31%539.23M
-1.25%539.23M
-1.89%547.35M
-1.75%546.86M
-1.48%546.4M
-1.11%546.04M
-0.46%557.91M
1.41%556.62M
Surplus reserve funds
4.75%75.02M
4.75%75.02M
4.75%75.02M
4.75%75.02M
8.61%71.62M
8.61%71.62M
8.61%71.62M
8.61%71.62M
21.39%65.94M
21.39%65.94M
Retained profit
-7.93%435.34M
-6.89%414.95M
-4.71%461.63M
-1.01%463.83M
-2.61%472.84M
2.11%445.65M
2.19%484.44M
4.10%468.57M
9.49%485.52M
10.23%436.44M
Shareholders equity without minority interests
-2.81%1.46B
-2.37%1.44B
-1.76%1.49B
-0.54%1.49B
-1.15%1.5B
0.35%1.47B
0.52%1.51B
1.22%1.5B
3.48%1.52B
4.31%1.47B
Minority interests
-20.26%15.44M
--16.41M
--17.42M
--18.34M
428.05%19.36M
----
----
----
-196.80%-5.9M
-196.39%-5.9M
Total shareholder equity
-3.03%1.48B
-1.26%1.46B
-0.61%1.5B
0.68%1.51B
0.51%1.52B
0.75%1.47B
0.92%1.51B
1.62%1.5B
3.22%1.51B
4.04%1.46B
Total liabilityies and equity
-1.82%1.58B
0.29%1.56B
-0.38%1.59B
-0.69%1.59B
-1.80%1.61B
-1.62%1.55B
-0.88%1.6B
0.41%1.61B
1.73%1.64B
3.42%1.58B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 169.49%105.11M-7.09%138.28M-10.77%40.94M-14.73%44.98M54.11%39.01M130.91%148.84M-13.51%45.88M19.29%52.74M-69.53%25.31M-64.26%64.46M
Transactional financial assets -57.87%60.96M-55.22%40.51M-50.46%132.32M-46.78%162.38M-51.65%144.68M-69.30%90.45M-24.72%267.09M-28.05%305.12M-15.93%299.22M-0.35%294.66M
Notes receivable and accounts receivable -3.15%315.11M5.83%272.3M17.12%313.4M22.99%273.97M8.15%325.35M31.55%257.29M21.71%267.58M44.07%222.76M36.99%300.84M24.06%195.58M
-Notes receivable -------------------------98.68%33.12K-83.20%604.82K--2.52M--1.92M
-Accounts receivable -3.15%315.11M5.83%272.3M17.14%313.4M23.33%273.97M9.06%325.35M32.86%257.29M23.09%267.55M47.11%222.15M35.84%298.31M22.84%193.66M
Other receivables (including interest and dividends) -7.32%3.58M25.12%3.84M-22.78%4.83M-54.71%3.09M-42.02%3.86M-64.62%3.07M1.66%6.25M13.68%6.82M7.94%6.65M34.92%8.68M
-Other receivable ----25.12%3.84M-----54.71%3.09M-----64.62%3.07M----13.68%6.82M----34.92%8.68M
Advance payment -70.62%1.17M-81.06%1.17M-36.72%1.8M-23.64%2.09M-7.68%4M-8.14%6.2M61.27%2.85M139.96%2.74M267.24%4.33M583.62%6.75M
Inventories -17.42%95.05M-5.76%114.2M1.04%112M-3.07%111.79M8.60%115.11M0.10%121.18M7.39%110.85M11.51%115.33M3.60%106M70.78%121.06M
Other current assets --59.66K-91.14%56.52K--------------637.79K----------------
Total current assets -8.06%581.04M-9.13%570.36M-13.59%605.3M-15.20%598.29M-14.87%632M-9.19%627.66M-5.19%700.5M-3.81%705.5M-3.37%742.35M-2.93%691.19M
Non Current assets
Fixed assets -----1.24%651.51M-----2.79%658.33M-----4.52%659.7M----6.78%677.24M----16.01%690.96M
Constru in process ----28.73%156.52M----65.18%163.44M----43.40%121.6M-----26.04%98.95M-----35.49%84.79M
Productive biological assets --139.36K--156.97K--197.1K--206.46K------------------------
Intangible assets 10.06%104.97M39.25%107.17M99.97%104.56M76.20%93.6M182.83%95.37M136.43%76.96M60.91%52.29M62.65%53.12M3.55%33.72M-0.72%32.55M
Development expenditure 21.80%49.9M19.38%45.86M-30.45%31.06M0.44%42.35M-27.10%40.97M-12.98%38.42M10.26%44.66M18.70%42.17M127.72%56.19M166.81%44.15M
Deferred tax assets -1.96%7.27M-13.23%5.74M-18.76%5.51M-20.99%5.14M-11.32%7.41M-20.83%6.61M-9.90%6.78M-8.18%6.5M-4.77%8.36M-15.29%8.35M
Usufruct assets 39.12%1.96M53.44%2.29M-20.95%1.24M182.92%1.33M180.02%1.41M201.18%1.49M198.76%1.57M-16.04%468.82K-14.72%503.13K-20.34%495.15K
Other non current assets -3.70%28.43M-14.47%15.98M31.23%28.29M51.96%29.72M39.22%29.52M-23.05%18.68M11.13%21.56M-0.29%19.56M-39.81%21.21M-5.44%24.27M
Total non current assets 2.20%1B6.68%986.81M9.91%988.85M10.69%995.7M8.99%979.38M4.27%925.04M2.76%899.67M4.00%899.58M6.38%898.63M8.98%887.15M
Total assets -1.82%1.58B0.29%1.56B-0.38%1.59B-0.69%1.59B-1.80%1.61B-1.62%1.55B-0.88%1.6B0.41%1.61B1.73%1.64B3.42%1.58B
Liabilities
Current liabilities
Notes payable and accounts payable -14.60%8.27M-52.57%3.5M42.32%10.3M-41.94%5.14M-43.59%9.69M-43.85%7.39M-43.37%7.23M-21.82%8.86M5.07%17.17M111.47%13.16M
-Accounts payable -14.60%8.27M-52.57%3.5M42.32%10.3M-41.94%5.14M-43.59%9.69M-43.85%7.39M-43.37%7.23M-21.82%8.86M5.07%17.17M111.47%13.16M
Contract liabilities 25.03%12.29M19.30%18.54M27.28%8.36M-36.73%6.65M-15.15%9.83M-7.59%15.54M132.14%6.57M26.24%10.51M-61.77%11.59M-20.72%16.81M
Salaries payable 115.41%13.66M49.60%9.32M48.51%7.95M-11.59%18.22M-60.25%6.34M-42.42%6.23M-37.87%5.35M-13.48%20.61M-7.90%15.96M-13.50%10.82M
Taxs payable -61.93%2.87M38.04%1.13M-46.88%5.03M-82.11%2.35M-69.42%7.54M-93.77%818.63K-41.56%9.47M50.92%13.11M90.87%24.64M209.97%13.14M
Other payable (including interest and dividends) 38.83%45.77M66.75%44.62M10.52%38.21M8.42%33.88M0.20%32.96M-14.51%26.76M-23.72%34.58M-29.63%31.25M-10.44%32.9M-23.36%31.3M
-Dividend payable 6.56%553.01K-47.07%1.88M17.65%518.95K17.65%518.95K17.65%518.95K705.15%3.55M50.00%441.1K50.00%441.1K50.00%441.1K50.00%441.1K
-Other payable ----84.17%42.74M----8.29%33.36M-----24.80%23.21M-----30.16%30.81M-----23.90%30.86M
Non current liabilities due within one year 50.37%520.13K62.29%563.04K-5.36%329.87K145.41%333.81K150.21%345.91K169.89%346.94K167.90%348.56K3.29%136.02K3.74%138.25K-4.67%128.55K
Other current liabilities -5.28%11.22M11.75%10.78M-14.85%9.9M-22.06%9.93M-10.90%11.84M-45.44%9.65M-33.16%11.63M-24.27%12.74M-35.11%13.29M-19.24%17.68M
Total current liabilities 20.43%94.6M32.56%88.46M6.52%80.08M-21.31%76.5M-32.10%78.55M-35.25%66.73M-27.21%75.18M-14.37%97.22M-13.82%115.69M-3.74%103.05M
Current liabilities
Long term account payable --------------------------------------0
Specific account payable --------------------------------------100K
Deferred tax liabilities -81.23%73.51K-95.09%14.25K-98.40%10.73K-94.44%17.88K97.31%391.6K-1.11%290.53K93.65%669.38K20.71%321.82K45.70%198.47K178.63%293.8K
Long term deferred income 7.46%10.43M8.91%10.81M-8.63%9.27M-8.45%9.49M-8.28%9.71M-8.11%9.93M-7.95%10.15M-8.27%10.36M-6.62%10.58M-7.10%10.8M
Lease liabilities 36.32%1.23M65.37%1.63M-21.41%842.56K195.92%917.19K195.81%899.97K178.73%985.8K206.38%1.07M-18.91%309.94K-26.59%304.24K-20.83%353.68K
Total non current liabilities 6.66%11.73M11.18%12.45M-14.84%10.12M-5.21%10.42M-1.67%11M-3.00%11.2M1.45%11.89M-7.96%11M-5.87%11.19M-5.18%11.55M
Total liabilities 18.74%106.34M29.49%100.91M3.60%90.21M-19.67%86.93M-29.42%89.55M-32.00%77.93M-24.29%87.07M-13.76%108.21M-13.17%126.88M-3.89%114.6M
Shareholders equity
Paid-in capital 0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.00%410.64M0.23%410.64M
Capital reserve funds -1.48%539.23M-1.39%539.23M-1.31%539.23M-1.25%539.23M-1.89%547.35M-1.75%546.86M-1.48%546.4M-1.11%546.04M-0.46%557.91M1.41%556.62M
Surplus reserve funds 4.75%75.02M4.75%75.02M4.75%75.02M4.75%75.02M8.61%71.62M8.61%71.62M8.61%71.62M8.61%71.62M21.39%65.94M21.39%65.94M
Retained profit -7.93%435.34M-6.89%414.95M-4.71%461.63M-1.01%463.83M-2.61%472.84M2.11%445.65M2.19%484.44M4.10%468.57M9.49%485.52M10.23%436.44M
Shareholders equity without minority interests -2.81%1.46B-2.37%1.44B-1.76%1.49B-0.54%1.49B-1.15%1.5B0.35%1.47B0.52%1.51B1.22%1.5B3.48%1.52B4.31%1.47B
Minority interests -20.26%15.44M--16.41M--17.42M--18.34M428.05%19.36M-------------196.80%-5.9M-196.39%-5.9M
Total shareholder equity -3.03%1.48B-1.26%1.46B-0.61%1.5B0.68%1.51B0.51%1.52B0.75%1.47B0.92%1.51B1.62%1.5B3.22%1.51B4.04%1.46B
Total liabilityies and equity -1.82%1.58B0.29%1.56B-0.38%1.59B-0.69%1.59B-1.80%1.61B-1.62%1.55B-0.88%1.6B0.41%1.61B1.73%1.64B3.42%1.58B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data